MCH ANALYSIS RESEARCHMain site ↗
Financials

Diversified Banks

7 companies under coverage.

Coverage

Diversified Banks


Equity Research

U.S. Bancorp (USB)

HOLD. 12-month probability-weighted target $59 (+4% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

USBEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -0.6%
Equity Research

PNC Financial Services Group Inc (PNC)

HOLD. 12-month probability-weighted target $237 (+8% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

PNCEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -0.9%
Equity Research

Truist Financial Corp (TFC)

HOLD. 12-month probability-weighted target $50 (+8% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

TFCEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -1.1%
Equity Research

Wells Fargo & Company (WFC)

HOLD. 12-month probability-weighted target $83 (+0% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

WFCEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -7.0%
Equity Research

Bank of America Corp (BAC)

HOLD. 12-month probability-weighted target $57 (+5% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

BACEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -7.2%
Equity Research

Citigroup Inc. (C)

HOLD. 12-month probability-weighted target $144 (+11% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

CEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -8.1%
Equity Research

JPMorgan Chase & Co. (JPM)

SELL. 12-month probability-weighted target $294 (-12% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

JPMEquity ResearchMonte Carlo
12 October 2026Rating: SELL · Fair value vs price -10.6%
MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies